WSES consensus conference: Guidelines for first-line management of intra-abdominal infections

World Journal of Emergency Surgery

Volumn 6, Issue 1, 2011, Pages

  Sartelli, Massimo ^a   Viale, Pierluigi ^b   Koike, Kaoru ^c   Pea, Federico ^d   Tumietto, Fabio ^b   van Goor, Harry ^e   Guercioni, Gianluca ^f   Nespoli, Angelo ^g   Tranà, Cristian ^h   Catena, Fausto ^b   Ansaloni, Luca ⁱ   Leppaniemi, Ari ^j   Biffl, Walter ^k   Moore, Frederick A ^l   Poggetti, Renato ^m   Pinna, Antonio D ^b   Moore, Ernest E ^k  

^a Macerata Hospital   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF UDINE   (Italy)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^f Ospedale Mazzoni   (Italy)

^g UNIVERSITY OF MILANO BICOCCA   (Italy)

^h UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

ⁱ OSPEDALI RIUNITI   (Italy)

^j HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^k DENVER HEALTH MEDICAL CENTER   (United States)

^l UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^m UNIVERSITY OF SÃO PAULO   (Brazil)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78651324477     PISSN: None     EISSN: 17497922     Source Type: Journal    
DOI: 10.1186/1749-7922-6-2     Document Type: Review

References (278)

1. Solomkin JS, Mazuski JE, Bradley JS, Rodvold KA, Goldstein EJ, Baron EJ, O'Neill PJ, Chow AW, Dellinger EP, Eachempati SR, Gorbach S, Hilfiker M, May AK, Nathens AB, Sawyer RG, Bartlett JG. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis 2010, 15,50(2):133-6.
2. Guyatt G, Gutterman D, Baumann MH, Addrizzo-Harris D, Hylek EM, Phillips B, Raskob G, Lewis SZ, Schunemann H. Grading strength of recommendations and quality of evidence in clinical guidelines: Report from an American College of Chest Physicians task force. Chest 2006, 129:174-181. 10.1378/chest.129.1.174, 16424429.
3. Brozek JL, Akl EA, Jaeschke R, Lang DM, Bossuyt P, Glasziou P, Helfand M, Ueffing E, Alonso-Coello P, Meerpohl J, Phillips B, Horvath AR, Bousquet J, Guyatt GH, Schunemann HJ. Grading quality of evidence and strength of recommendations in clinical practice guidelines: Part 2 of 3. The GRADE approach to grading quality of evidence about diagnostic tests and strategies. Allergy 2009, 64:1109-1116. 10.1111/j.1398-9995.2009.02083.x, 19489757.
4. Moore LJ, Moore FA, Jones SL, Xu J, Bass BL. Sepsis in general surgery: a deadly complication. Am J Surg 2009, 198(6):868-74. 10.1016/j.amjsurg.2009.05.025, 19969144.
5. Moore LJ, Moore FA, Todd SR, Jones SL, Turner KL, Bass BL. Sepsis in general surgery: the 2005-2007 national surgical quality improvement program perspective. Arch Surg 2010, 145(7):695-700. 10.1001/archsurg.2010.107, 20644134.
6. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL, . International Surviving Sepsis Campaign Guidelines Committee; American Association of Critical-Care Nurses; American College of Chest Physicians; American College of Emergency Physicians; Canadian Critical Care Society; European Society of Clinical Microbiology and Infectious Diseases; European Society of Intensive Care Medicine; European Respiratory Society; International Sepsis Forum; Japanese Association for Acute Medicine; Japanese Society of Intensive Care Medicine; Society of Critical Care Medicine; Society of Hospital Medicine; Surgical Infection Society; World Federation of Societies of Intensive and Critical Care Medicine Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008, 36(1):296-327. 10.1097/01.CCM.0000298158.12101.41, 18158437, International Surviving Sepsis Campaign Guidelines Committee; American Association of Critical-Care Nurses; American College of Chest Physicians; American College of Emergency Physicians; Canadian Critical Care Society; European Society of Clinical Microbiology and Infectious Diseases; European Society of Intensive Care Medicine; European Respiratory Society; International Sepsis Forum; Japanese Association for Acute Medicine; Japanese Society of Intensive Care Medicine; Society of Critical Care Medicine; Society of Hospital Medicine; Surgical Infection Society; World Federation of Societies of Intensive and Critical Care Medicine.
7. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ, . American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Definitions for sepsis and organ failure and guidlines for the use of innovative therapies in sepsis. Chest 1992, 101:1644-1655. 10.1378/chest.101.6.1644, 1303622, American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference.
8. Calandra T. Pathogenesis of septic shock: implications for prevention and treatment. J Chemother 2001, 13(Spec No 1(1)):173-80. Review.
9. Bochud PY, Calandra T. Pathogenesis of sepsis: new concepts and implications for future treatment. BMJ 2003 326:262-6.
10. Dinarello CA. Proinfiammatory and anti-infiammatory cytokines as mediators in the pathogenesis of septic shock. Chest 1997, 112:321S-329S. 10.1378/chest.112.6_Supplement.321S, 9400897.
11. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M, . Early Goal-Directed Therapy Collaborative Group Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Eng J Med 2001, 345:1368-1377. Early Goal-Directed Therapy Collaborative Group.
12. Vincent JL, Biston P, Devriendt J, Brasseur A, De Backer D. Dopamine versus norepinephrine: is one better?. Minerva Anestesiol 2009, 75(5):333-337.
13. Hollenberg SM. Vasopressor support in septic shock. Chest 2007, 132(5):1678-1687. 10.1378/chest.07-0291, 17998371.
14. Bellomo R, Chapman M, Finfer S, Hickling K, Myburgh J. Low-dose dopamine in patients with early renal dysfunction: A placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet 2000, 356:2139-2143. 10.1016/S0140-6736(00)03495-4, 11191541.
15. Kellum J, Decker J. Use of dopamine in acute renal failure: A meta-analysis. Crit Care Med 2001, 29:1526-1531. 10.1097/00003246-200108000-00005, 11505120.
16. Hesselvik JF, Brodin B. Low dose norepinephrine in patients with septic shock and oliguria: effects on afterload, urine flow, and oxygen transport. Crit Care Med 1989, 17:179-180. 10.1097/00003246-198902000-00016, 2914453.
17. Meadows D, Edwards JD, Wilkins RG, Nightingale P. Reversal of intractable septic shock with norepinephrine therapy. Crit Care Med 1988, 16:663-667. 10.1097/00003246-198807000-00003, 3371042.
18. Martin C, Papazian L, Perrin G, Saux P, Gouin F. Norepinephrine or dopamine for the treatment of hyperdynamic septic shock. Chest 1993, 103:1826-1831. 10.1378/chest.103.6.1826, 8404107.
19. Patel GP, Grahe JS, Sperry M, Singla S, Elpern E, Lateef O, Balk RA. Efficacy and safety of dopamine versus norepinephrine in the management of septic shock. Shock 2010, 33(4):375-80. 10.1097/SHK.0b013e3181c6ba6f, 19851126.
20. Flancbaum L, Dick M, Dasta J, Sinha R, Choban P. A dose-response study of phenylephrine in critically ill, septic surgical patients. Eur J Clin Pharmacol 1997, 51:461-465. 10.1007/s002280050231, 9112060.
21. De Backer D, Creteur J, Silva E, Vincent JL. Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is best?. Crit Care Med 2003, 31(6):1659-67. 10.1097/01.CCM.0000063045.77339.B6, 12794401.
22. Hollenberg SM, Ahrens TS, Annane D, Astiz ME, Chalfin DB, Dasta JF, Heard SO, Martin C, Napolitano LM, Susla GM, Totaro R, Vincent JL, Zanotti-Cavazzoni S. Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update. Crit Care Med 2004, 32:1928-1948. 10.1097/01.CCM.0000139761.05492.D6, 15343024.
23. Annane D, Vignon P, Renault A, Bollaert PE, Charpentier C, Martin C, Troché G, Ricard JD, Nitenberg G, Papazian L, Azoulay E, Bellissant E, . CATS Study Group Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial. Lancet 2007, 370(9588):676-84. 10.1016/S0140-6736(07)61344-0, 17720019, CATS Study Group.
24. Holmes CL, Patel BM, Russell JA, Walley KR. Physiology of vasopressin relevant to management of septic shock. Chest 2001, 120(3):989-1002. 10.1378/chest.120.3.989, 11555538.
25. Russell JA, Walley KR, Singer J, Gordon AC, Hébert PC, Cooper DJ, Holmes CL, Mehta S, Granton JT, Storms MM, Cook DJ, Presneill JJ, Ayers D, . VASST Investigators Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008, 358(9):877-87. 10.1056/NEJMoa067373, 18305265, VASST Investigators.
26. Azzarello G, Lanteri R, Rapisarda C, Santangelo M, Racalbuto A, Minutolo V, Di Cataldo A, Licata A. Ultrasound-guided percutaneous treatment of abdominal collections. Chir Ital 2009, 61(3):337-340.
27. Gazelle GS, Mueller PR. Abdominal abscess: Imaging and intervention. Radiol Clin North Am 1994, 32:913-932.
28. VanSonnenberg E, Ferrucci JT, Mueller PR, Wittenberg J, Simeone JF. Percutaneous drainage of abscesses and fluid collections: Technique, results, and applications. Radiology 1982, 142:1-10.
29. Bouali K, Magotteaux P, Jadot A, Saive C, Lombard R, Weerts J, Dallemagne B, Jehaes C, Delforge M, Fontaine F. Percutaneous catheter drainage of abdominal abscess after abdominal surgery: Results in 121 cases. J Belg Radiol 1993, 76:11-14.
30. VanSonnenberg E, Wing VW, Casola G, Coons HG, Nakamoto SK, Mueller PR, Ferrucci JT, Halasz NA, Simeone JF. Temporizing effect of percutaneous drainage of complicated abscesses in critically ill patients. Am J Roentgenol 1984, 142:821-826.
31. Bufalari A, Giustozzi G, Moggi L. Postoperative intra-abdominal abscesses: Percutaneous versus surgical treatment. Acta Chir Belg 1996, 96(5):197-200.
32. VanSonnenberg E, Mueller PR, Ferrucci JT. Percutaneous drainage of 250 abdominal abscesses and fluid collections. I. Results, failures, and complications. Radiology 1984, 151:337-341.
33. Jaffe TA, Nelson RC, DeLong D, Paulson EK. Practice Patterns in Percutaneous Image-guided Intra-abdominal Abscess Drainage: Survey of Academic and Private Practice Centres. Radiology 2004, 233(3):750-6. 10.1148/radiol.2333032063, 15516608.
34. Shani V, Muchtar E, Kariv G, Robenshtok E, Leibovici L. Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis. Antimicrob Agents Chemother 2010, 54(11):4851-63. 10.1128/AAC.00627-10, 20733044.
35. Montravers P, Lepape A, Dubreuil L, Gauzit R, Pean Y, Benchimol D, Dupont H. Clinical and microbiological profiles of community-acquired and nosocomial intra-abdominal infections: results of the French prospective, observational EBIIA study. J Antimicrob Chemother 2009, 63(4):785-94. 10.1093/jac/dkp005, 19196742.
36. Swenson BR, Metzger R, Hedrick TL, McElearney ST, Evans HL, Smith RL, Chong TW, Popovsky KA, Pruett TL, Sawyer RG. Choosing antibiotics for intra-abdominal infections: what do we mean by high risk?. Surg Infect (Larchmt) 2009, 10(1):29-39. 10.1089/sur.2007.041, 19226202.
37. Montravers P, Dupont H, Gauzit R, Veber B, Auboyer C, Blin P, Hennequin C, Martin C. Candida as a risk factor for mortality in peritonitis. Crit Care Med 2006, 34(3):646-52. 10.1097/01.CCM.0000201889.39443.D2, 16505648.
38. Montravers P, Mira JP, Gangneux JP, Leroy O, Lortholary O, . the AmarCand study group A multicentre study of antifungal strategies and outcome of Candida spp. peritonitis in intensive-care units. Clin Microbiol Infect 2010, the AmarCand study group.
39. Lumb J. Carbapenems in the treatment of intra-abdominal infection. Report from the 20th European Congress of Clinical Microbiology and Infectious Diseases. Vienna, Austria, 10-13 April 2010. Future Microbiol 2010, 5(8):1165-6. 10.2217/fmb.10.87, 20722595.
40. Hawser SP, Bouchillon SK, Hoban DJ, Badal RE, Cantón R, Baquero F. Incidence and antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae with extended-spectrum beta-lactamases in community- and hospital-associated intra-abdominal infections in Europe: results of the 2008 Study for Monitoring Antimicrobial Resistance Trends (SMART). Antimicrob Agents Chemother 2010, 54(7):3043-6. 10.1128/AAC.00265-10, 2897323, 20421398.
41. Coque TM, Baquero F, Canton R. Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Euro Surveill 2008, 13(47)., http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19044
42. Vatopoulos A. High rates of metallo-beta-lactamase-producing Klebsiella neumoniae in Greece - a review of the current evidence. Euro Surveill 2008, 13(4).
43. Ho J, Tambyah PA, Paterson DL. Multiresistant Gram-negative infections: a global perspective. Curr Opin Infect Dis 2010, 23(6):546-53. 10.1097/QCO.0b013e32833f0d3e, 20802331.
44. Ho J, Tambyah PA, Paterson DL. Multiresistant Gram-negative infections: a global perspective. Curr Opin Infect Dis 2010, 23(6):546-53. 10.1097/QCO.0b013e32833f0d3e, 20802331.
45. Riché FC, Dray X, Laisné MJ, Matéo J, Raskine L, Sanson-Le Pors MJ, Payen D, Valleur P, Cholley BP. Factors associated with septic shock and mortality in generalized peritonitis: Comparison between community-acquired and postoperative peritonitis. Crit Care 2009, 13(3):R99. 2717471, 19552799.
46. Pea F, Viale P, Furlanut M. Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability. Clin Pharmacokinet 2005, 44:1009-1034. 10.2165/00003088-200544100-00002, 16176116.
47. Pea F, Viale P. Bench-to-bedside review: Appropriate antibiotic therapy in severe sepsis and septic shock--does the dose matter?. Crit Care 2009, 13(3):214. 10.1186/cc7774, 2717408, 19519961.
48. Ho J, Tambyah PA, Paterson DL. Multiresistant Gram-negative infections: a global perspective. Curr Opin Infect Dis 2010, 23(6):546-53. 10.1097/QCO.0b013e32833f0d3e, 20802331.
49. Pea F, Brollo L, Viale P, Pavan F, Furlanut M. Teicoplanin therapeutic drug monitoring in critically ill patients: a retrospective study emphasizing the importance of a loading dose. J Antimicrob Chemother 2003, 51(4):971-5. 10.1093/jac/dkg147, 12654757.
50. Pea F, Viale P. The antimicrobial therapy puzzle: could pharmacokinetic-pharmacodynamic relationships be helpful in addressing the issue of appropriate pneumonia treatment in critically ill patients?. Clin Infect Dis 2006, 42(12):1764-71. 10.1086/504383, 16705585.
51. Craig WA. Basic pharmacodynamics of antibacterials with clinical applications to the use of beta-lactams, glycopeptides, and linezolid. Infect Dis Clin North Am 2003, 17(3):479-501. 10.1016/S0891-5520(03)00065-5, 14711073.
52. Lorente L, Jiménez A, Martín MM, et al. Clinical cure of ventilator-associated pneumonia treated with piperacillin/tazobactam administered by continuous or intermittent infusion. Int J Antimicrob Agents 2009, 33(5):464-8. 10.1016/j.ijantimicag.2008.10.025, 19150225.
53. Lorente L, Lorenzo L, Martín MM, Jiménez A, Mora ML. Meropenem by continuous versus intermittent infusion in ventilator-associated pneumonia due to gram-negative bacilli. Ann Pharmacother 2006, 40(2):219-23. 10.1345/aph.1G467, 16449546.
54. Roberts JA, Lipman J, Blot S, Rello J. Better outcomes through continuous infusion of time-dependent antibiotics to critically ill patients?. Curr Opin Crit Care 2008, 14(4):390-6. 10.1097/MCC.0b013e3283021b3a, 18614901.
55. Mueller EW, Boucher BA. The use of extended-interval aminoglycoside dosing strategies for the treatment of moderate-to-severe infections encountered in critically ill surgical patients. Surg Infect (Larchmt) 2009, 10(6):563-70. 10.1089/sur.2007.080, 20035611.
56. Chakraborty A, Roy S, Loeffler J, Chaves RL. Comparison of the pharmacokinetics, safety and tolerability of daptomycin in healthy adult volunteers following intravenous administration by 30 min infusion or 2 min injection. J Antimicrob Chemother 2009, 64(1):151-8. 10.1093/jac/dkp155, 2692502, 19389714.
57. Menichetti F, Sganga G. Definition and classification of intra-abdominal infections. J Chemother 2009, (Suppl 1):3-4.
58. Malangoni MA, Inui T. Peritonitis - the Western experience. World J Emerg Surg 2006, 1:25. 10.1186/1749-7922-1-25, 1592073, 16953882.
59. Pieracci FM, Barie PS. Management of severe sepsis of abdominal origin. Scand J Surg 2007, 96(3):184-96.
60. Osborn TM, Nguyen HB, Rivers EP. Emergency medicine and the surviving sepsis campaign: an international approach to managing severe sepsis and septic shock. Ann Emerg Med 2005, 46(3):228-31. 10.1016/j.annemergmed.2005.04.007, 16126131.
61. Esteban A, Frutos-Vivar F, Ferguson ND, Peñuelas O, Lorente JA, Gordo F, Honrubia T, Algora A, Bustos A, García G, Diaz-Regañón IR, de Luna RR. Sepsis incidence and outcome: contrasting the intensive care unit with the hospital ward. Crit Care Med 2007, 35(5):1284-9. 10.1097/01.CCM.0000260960.94300.DE, 17414725.
62. Emmi V, Sganga G. Diagnosis of intra-abdominal infections: clinical findings and imaging. Infez Med 2008, (Suppl 1):19-30.
63. Bartolozzi C. Imaging and invasive techniques for diagnosis and treatment of surgical infections. Surg Infect (Larchmt) 2006, 7(Suppl 2):S97-9.
64. Foinant M, Lipiecka E, Buc E, Boire JY, Schmidt J, Garcier JM, Pezet D, Boyer L. Impact of computed tomography on patient's care in non-traumatic acute abdomen: 90 patients. J Radiol 2007, 88(4):559-566. 10.1016/S0221-0363(07)89855-6, 17464254.
65. Emmi V, Sganga G. Clinical diagnosis of intra-abdominal infections. J Chemother 2009, 21(Suppl 1):12-8.
66. Puylaert JB, van der Zant FM, Rijke AM. Sonography and the acute abdomen: practical considerations. Am J Roentgenol 1997, 168(1):179-86.
67. Doria AS, Moineddin R, Kellenberger CJ, Epelman M, Beyene J, Schuh S, Babyn PS, Dick PT. US or CT for diagnosis of appendicitis in children and adults? A meta-analysis. Radiology 2006, 241:83-94. 10.1148/radiol.2411050913, 16928974.
68. TJ, Park KG, Steele RJ, Chung SS, Li AK. A randomized trial of nonoperative treatment for perforated peptic ulcer. N Engl J Med 1989, 320:970-973. 10.1056/NEJM198904133201504, 2927479.
69. Boey J, Lee NW, Koo J, Lam PH, Wong J, Ong GB. Immediate definitive surgery for perforated duodenal ulcers: a prospective controlled trial. Ann Surg 1982, 196:338-344. 10.1097/00000658-198209000-00013, 7114938.
70. Millat B, Fingerhut A, Borie F. Surgical treatment of complicated duodenal ulcers: controlled trials. World J Surg 2000, 24:299-306. 10.1007/s002689910048, 10658064.
71. Crisp E. Cases of perforation of the stomach with deductions therefrom relative to the character and treatment of that lesion. Lancet 1843(2):639.
72. Wangensteen OH. Nonoperative treatment of localized perforations of the duodenum. Minn Med 1935, 18:477-480.
73. Taylor H. Peptic ulcer perforation treated without operation. Lancet 1946, 2:441-444. 10.1016/S0140-6736(46)90971-3, 20998912.
74. Crofts TJ, Park KG, Steele RJ, Chung SS, Li AK. A randomized trial of nonoperative treatment for perforated peptic ulcer. N Engl J Med 1989, 320:970-973. 10.1056/NEJM198904133201504, 2927479.
75. Bucher P, Oulhaci W, Morel P, Ris F, Huber O. Results of conservative treatment for perforated gastroduodenal ulcers in patients not eligible for surgical repair. Swiss Med Wkly 2007, 137:337-340.
76. Sogne B, Jean F, Foulatier O, Khalil H, Scotté M. Non operative treatment for perforated peptic ulcer: results of a prospective study. Ann Chir 2004, 129:578-582. 10.1016/j.anchir.2004.06.012, 15581818.
77. Crofts TJ, Park KG, Steele RJ, Chung SS, Li AK. A randomized trial of nonoperative treatment for perforated peptic ulcer. N Engl J Med 1989, 320:970-973. 10.1056/NEJM198904133201504, 2927479.
78. Bucher P, Oulhaci W, Morel P, Ris F, Huber O. Results of conservative treatment for perforated gastroduodenal ulcers in patients not eligible for surgical repair. Swiss Med Wkly 2007, 137:337-340.
79. Sogne B, Jean F, Foulatier O, Khalil H, Scotté M. Non operative treatment for perforated peptic ulcer: results of a prospective study. Ann Chir 2004, 129:578-582. 10.1016/j.anchir.2004.06.012, 15581818.
80. Boey J, Choi SKI, Poon A, et al. Risk stratification in perforated duodenal ulcers. Ann Surg 1987, 205:22-26. 10.1097/00000658-198701000-00005, 1492892, 3800459.
81. Crofts TJ, Park KG, Steele RJ, Chung SS, Li AK. A randomized trial of nonoperative treatment for perforated peptic ulcer. N Engl J Med 1989, 320:970-973. 10.1056/NEJM198904133201504, 2927479.
82. Sogne B, Jean F, Foulatier O, Khalil H, Scotté M. Non operative treatment for perforated peptic ulcer: results of a prospective study. Ann Chir 2004, 129:578-5827. 10.1016/j.anchir.2004.06.012, 15581818.
83. Svanes C, Lie RT, Svanes K, Lie SA, Soreide O. Adverse effects of delayed treatment for perforated peptic ulcer. Ann Surg 1994, 220(2):168-75. 10.1097/00000658-199408000-00008, 1234356, 8053739.
84. Boey J, Lee NW, Koo J, Lam PH, Wong J, Ong GB. Immediate definitive surgery for perforated duodenal ulcers: a prospective controlled trial. Ann Surg 1982, 196:338-344. 10.1097/00000658-198209000-00013, 7114938.
85. Tanphiphat C, Tanprayoon T, Nathalong A. Surgical treatment of perforated duodenal ulcer: A prospective trial between simple closure and definitive surgery. Br J Surg 1985, 72:370. 10.1002/bjs.1800720513, 3888337.
86. Christiansen J, Andersen OB, Bonnesen T, Baekgaard N. Perforated duodenal ulcer managed by simple closure versus closure and proximal gastric vagotomy. Br J Surg 1987, 74(4):286-7. 10.1002/bjs.1800740420, 3555692.
87. Hay JM, Lacaine F, Kohlmann G, Fingerhut A. Immediate definitive surgery for perforated duodenal ulcer does not increase operative mortality: a prospective controlled trial. World J Surg 1988, 12(5):705-9. 10.1007/BF01655894, 3072779.
88. Mikulicz J. Ueber Laparotomie bei Magen und Darmperforation. Samml Klin Vort Leipzig 1885, 262:2307.
89. Cellan-Jones CJ. A rapid method of treatment in perforated duodenal ulcer. BMJ 1929, 1076-1077. 10.1136/bmj.1.3571.1076, 2450792, 20774747.
90. Graham RR. The treatment of perforated duodenal ulcers. Surg Gynecol Obstet 1937, 235-238.
91. Lau WY, Leung KL, Kwong KH, Davey IC, Robertson C, Dawson JJ, Chung SC, Li AK. A randomized study comparing laparoscopic versus open repair of perforated peptic ulcer using suture or sutureless technique. Ann Surg 1996, 224:131-138. 10.1097/00000658-199608000-00004, 8757375.
92. Boey J, Lee NW, Koo J, Lam PH, Wong J, Ong GB. Immediate definitive surgery for perforated duodenal ulcers: a prospective controlled trial. Ann Surg 1982, 196:338-344. 10.1097/00000658-198209000-00013, 1352612, 7114938.
93. Tanphiphat C, Tanprayoon T, Nathalong A. Surgical treatment of perforated duodenal ulcer: A prospective trial between simple closure and definitive surgery. Br J Surg 1985, 72:370. 10.1002/bjs.1800720513, 3888337.
94. Christiansen J, Andersen OB, Bonnesen T, Baekgaard N. Perforated duodenal ulcer managed by simple closure versus closure and proximal gastric vagotomy. Br J Surg 1987, 74(4):286-7. 10.1002/bjs.1800740420, 3555692.
95. Hay JM, Lacaine F, Kohlmann G, Fingerhut A. Immediate definitive surgery for perforated duodenal ulcer does not increase operative mortality: a prospective controlled trial. World J Surg 1988, 12(5):705-9. 10.1007/BF01655894, 3072779.
96. Ng EK, Lam YH, Sung JJ, Yung MY, To KF, Chan AC, Lee DW, Law BK, Lau JY, Ling TK, Lau WY, Chung SC. Eradication of Helicobacter pylori prevents recurrence of ulcer after simple closure of duodenal ulcer perforation: randomized controlled trial. Ann Surg 2000, 231(2):153-8. 10.1097/00000658-200002000-00001, 1420980, 10674604.
97. Haberer V, Zur H. Therapie akuter Geschwursperforationen des Magens und Duodenums in die freie Bauchhohle. Wien Klin Wochnschr 1919, 32:413.
98. Sarath Chandra SS, Kumar SS. Definitive or conservative surgery for perforated gastric ulcer? An unresolved problem. Int J Surg 2009, 7:136-139. 10.1016/j.ijsu.2008.12.037, 19168409.
99. Turner WW, Thompson WM, Thal ER. Perforated gastric ulcers. A plea for management by simple closures. Arch Surg 1988, 123(8):960-4.
100. Wysocki A, Biesiada Z, Beben P, Budzynski A. Perforated gastric ulcer. Dig Surg 2000, 17:132-7. 10.1159/000018815, 10781975.
101. Tsugawa K, Koyanagi N, Hashizume M, Tomikawa M, Akahoshi K, Ayukawa K, et al. The therapeutic strategies in performing emergency surgery for gastroduodenal ulcer perforation in 130 patients over 70 years of age. Hepatogastroenterology 2001, 48(37):156-62.
102. Sanabria A, Villegas MI, Morales Uribe CH. Laparoscopic repair for perforated peptic ulcer disease. Cochrane Database of Systematic Reviews 2010, (Issue 4).
103. Lau H. Laparoscopic repair of perforated peptic ulcer: a meta-analysis. Surg Endosc 2004, 18(7):1013-21. 10.1007/s00464-003-8266-y, 15136924.
104. Lau WY, Leung KL, Kwong KH, Davey IC, Robertson C, Dawson JJ, Chung SC, Li AK. A randomized study comparing laparoscopic versus open repair of perforated peptic ulcer using suture or sutureless technique. Annals of Surgery 1996, 224:131-8. 10.1097/00000658-199608000-00004, 1235333, 8757375.
105. Siu WT, Leong HT, Law BK, Chau CH, Li AC, Fung KH, Tai YP, Li MK. Laparoscopic repair for perforated peptic ulcer: a randomized controlled trial. Annals of Surgery 2002, 235:313-9. 10.1097/00000658-200203000-00001, 1422436, 11882751.
106. Bertleff MJ, Halm JA, Bemelman WA, van der Ham AC, van der Harst E, Oei HI, Smulders JF, Steyerberg EW, Lange JF. Randomized clinical trial of laparoscopic versus open repair of the perforated peptic ulcer: the LAMA Trial. World Journal of Surgery 2009, 33:1368-73. 10.1007/s00268-009-0054-y, 2691927, 19430829.
107. Gertsch P, Choe LWC, Yuen ST, Chau KY, Lauder IJ. Long term survival after gastrectomy for advanced bleeding or perforated gastric carcinoma. Eur J Surg 1996, 162:723-727.
108. Lehnert T, Buhl K, Dueck M, Hinz U, Herfarth C. Two-stage radical gastrectomy for perforated gastric cancer. Eur J Surg Oncol 2000, 26:780-784. 10.1053/ejso.2000.1003, 11087645.
109. Ozmen MM, Zulfikaroglu B, Kece C, Aslar AK, Ozalp N, Koc M. Factors influencing mortality in spontaneous gastric tumour perforations. J Int Med Res 2002, 30:180-184.
110. So JBY, Yam A, Cheah WK, Kum CK, Goh PM. Risk factors related to operative mortality and morbidity in patients undergoing emergency gastrectomy. Br J Surg 2000, 87:1702-1707. 10.1046/j.1365-2168.2000.01572.x, 11122188.
111. Roviello F, Simone R, Marrelli D, et al. Perforated gastric carcinoma: a report of 10 cases and review of the literature. World J Surg Oncol 2006, 4:19-24. 10.1186/1477-7819-4-19, 1524767, 16573818.
112. Jwo S, Chien R, Chao T, et al. Clinicopathalogical features, surgical management, and disease outcome of perforated gastric cancer. J Surg Oncol 2005, 91:219-25. 10.1002/jso.20307, 16121341.
113. Adachi Y, Mori M, Maehara Y, et al. Surgical results of perforated gastric carcinoma: an analysis of 155 Japanese patients. Am J Gastroenterol 1997, 92:516-8.
114. Lehnert T, Buhl K, Dueck M, et al. Two-stage radical gastrectomy for perforated gastric cancer. Eur J Surg Oncol 2000, 26:780-4. 10.1053/ejso.2000.1003, 11087645.
115. Ayite A, Dosseh DE, Tekou HA, James K. Surgical treatment of singl non traumatic perforation of small bowel: excision-suture or resection-anastomosis. Ann Chir 2005, 131(2):91-5. (EL 3b), 10.1016/j.anchir.2005.11.008, 16376845.
116. Kirkpatrick AW, Baxter KA, Simons RK, Germann E, Lucas CE, Ledgerwood AM. Intra-abdominal complications after surgical repair of small bowel injuries: an international reiew. J Trauma 2003, 55(3):399-406. 10.1097/01.TA.0000060248.87046.EE, 14501878.
117. Kirkpatrick AW, Baxter KA, Simons RK, Germann E, Lucas CE, Ledgerwood AM. Intra-abdominal complications after surgical repair of small bowel injuries: an international reiew. J Trauma 2003, 55(3):399-406. 10.1097/01.TA.0000060248.87046.EE, 14501878.
118. Ayite A, Dosseh DE, Tekou HA, James K. Surgical treatment of single non traumatic perforation of small bowel: excision-suture or resection-anastomosis. Ann Chir 2005, 131(2):91-5. (EL 3b), 10.1016/j.anchir.2005.11.008, 16376845.
119. Kirkpatrick AW, Baxter KA, Simons RK, Germann E, Lucas CE, Ledgerwood AM. Intra-abdominal complications after surgical repair of small bowel injuries: an international reiew. J Trauma 2003, 55(3):399-406. 10.1097/01.TA.0000060248.87046.EE, 14501878.
120. Kirkpatrick AW, Baxter KA, Simons RK, Germann E, Lucas CE, Ledgerwood AM. Intra-abdominal complications after surgical repair of small bowel injuries: an international reiew. J Trauma 2003, 55(3):399-406. 10.1097/01.TA.0000060248.87046.EE, 14501878.
121. De Graaf JS, van Goor H, Blechrodt RP. Primary small bowel anastomosis in generalized peritonitis. Eur j Surg 1996, 162(1):55-8.
122. Sinha R, Sharma N, Joshi M. Laparoscopic repair of small bowel perforation. JSLS 2005, 9:399-402.
123. Hansson J, Körner U, Khorram-Manesh A, Solberg A, Lundholm K. Randomized clinical trial of antibiotic therapy versus appendicectomy as primary treatment of acute appendicitis in unselected patients. Br J Surg 2009, 96:473-481. 10.1002/bjs.6482, 19358184.
124. Styrud J, Eriksson S, Nilsson I, Ahlberg G, Haapaniemi S, Neovius G, Rex L, Badume I, Granström L. Appendectomy versus antibiotic treatment in acute appendicitis. A prospective multicenter randomized controlled trial. World J Surg 2006, 30:1033-1037. 10.1007/s00268-005-0304-6, 16736333.
125. Eriksson S, Granström L. Randomized controlled trial of appendicectomy versus antibiotic therapy for acute appendicitis. Br J Surg 1995, 82:166-169. 10.1002/bjs.1800820207, 7749676.
126. Varadhan KK, Humes DJ, Neal KR, Lobo DN. Antibiotic therapy versus appendectomy for acute appendicitis: a meta-analysis. World J Surg 2010, 34:199-209. 10.1007/s00268-009-0343-5, 20041249.
127. Taylor M, Emil S, Nguyen N, Ndiforchu F. Emergent vs urgent appendectomy in children: a study of outcomes. J Pediatr Surg 2005, 40:1912-1915. 10.1016/j.jpedsurg.2005.08.005, 16338317.
128. Ditillo MF, Dziura JD, Rabinovici R. Is it safe to delay appendectomy in adults with acute appendicitis?. Ann Surg 2006, 244:656-660. 10.1097/01.sla.0000231726.53487.dd, 1856602, 17060754.
129. Sauerland S, Lefering R, Neugebauer EA. Laparoscopic versus open surgery for suspected appendicitis. Cochrane Database Syst Rev 2002, CD001546.
130. Faiz O, Clark J, Brown T, Bottle A, Antoniou A, Farrands P, Darzi A, Aylin P. Traditional and laparoscopic appendectomy in adults: outcomes in English NHS hospitals between 1996 and 2006. Ann Surg 2008, 248:800-806. 10.1097/SLA.0b013e31818b770c, 18948807.
131. Sporn E, Petroski GF, Mancini GJ, Astudillo JA, Miedema BW, Thaler K. Laparoscopic appendectomy--is it worth the cost? Trend analysis in the US from 2000 to 2005. J Am Coll Surg 2009, 208:179-185. 10.1016/j.jamcollsurg.2008.10.026, 19228528.
132. Oliak D, Yamini D, Udani VM, Lewis RJ, Arnell T, Vargas H, Stamos MJ. Initial nonoperative management for periappendiceal abscess. Dis Colon Rectum 2001, 44:936-941. 10.1007/BF02235479, 11496072.
133. Brown CV, Abrishami M, Muller M, Velmahos GC. Appendiceal abscess: immediate operation or percutaneous drainage?. Am Surg 2003, 69:829-832.
134. Andersson RE, Petzold MG. Nonsurgical treatment of appendiceal abscess or phlegmon: a systematic review and meta-analysis. Ann Surg 2007, 246:741-748. 10.1097/SLA.0b013e31811f3f9f, 17968164.
135. Corfield L. Interval appendicectomy after appendiceal mass or abscess in adults: what is best practice?. Surg Today 2007, 37:1-4. 10.1007/s00595-006-3334-2, 17186336.
136. Kaminski A, Liu IL, Applebaum H, Lee SL, Haigh PI. Routine interval appendectomy is not justified after initial nonoperative treatment of acute appendicitis. Arch Surg 2005, 140:897-901. 10.1001/archsurg.140.9.897, 16175691.
137. Rafferty J, Shellito P, Hyman NH, Buie WD. Standards Committee of American Society of Colon and Rectal Surgeons: Practice parameters for sigmoid diverticulitis. Dis Colon Rectum 2006, 49:939-944. 10.1007/s10350-006-0578-2, 16741596.
138. Wong WD, Wexner SD, Lowry A, Vernava A, Burnstein M, Denstman F, Fazio V, Kerner B, Moore R, Oliver G, Peters W, Ross T, Senatore P, Simmang C. Practice parameters for the treatment of sigmoid diverticulitis--supporting documentation. The Standards Task Force. The American Society of Colon and Rectal Surgeons. Dis Colon Rectum 2000, 43:290-297. 10.1007/BF02258291, 10733108.
139. Patient Care Committee of the Society for Surgery of the Alimentary Tract (SSAT) Surgical treatment of diverticulitis. J Gastrointest Surg 1999, 3:212-213. 10.1016/S1091-255X(99)80037-7, 10885948, Patient Care Committee of the Society for Surgery of the Alimentary Tract (SSAT).
140. Stollman NH, Raskin JB. Diagnosis and management of diverticular disease of the colon in adults. Ad Hoc Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol 1999, 94:3110-3121. 10.1111/j.1572-0241.1999.01501.x, 10566700.
141. Köhler L, Sauerland S, Neugebauer E. Diagnosis and treatment of diverticular disease: results of a consensus development conference. The Scientific Committee of the European Association for Endoscopic Surgery.
142. Hinchey EJ, Schaal PG, Richards GK. Treatment of perforated diverticular disease of the colon. Adv Surg 1978, 12:85-109.
143. Ambrosetti P, Jenny A, Becker C, Terrier TF, Morel P. Acute left colonic diverticulitis--compared performance of computed tomography and water-soluble contrast enema: prospective evaluation of 420 patients. Dis Colon Rectum 2000, 43:1363-1367. 10.1007/BF02236631, 11052512.
144. Stollman N, Raskin JB. Diverticular disease of the colon. Lancet 2004, 363:631-639. 10.1016/S0140-6736(04)15597-9, 14987890.
145. Jacobs DO. Clinical practice. Diverticulitis. N Engl J Med 2007, 357:2057-2066. 10.1056/NEJMcp073228, 18003962.
146. Broderick-Villa G, Burchette RJ, Collins JC, Abbas MA, Haigh PI. Hospitalization for acute diverticulitis does not mandate routine elective colectomy. Arch Surg 2005, 140:576-581. 10.1001/archsurg.140.6.576, 15967905.
147. Mueller MH, Glatzle J, Kasparek MS, Becker HD, Jehle EC, Zittel TT, Kreis ME. Long-term outcome of conservative treatment in patients with diverticulitis of the sigmoid colon. Eur J Gastroenterol Hepatol 2005, 17:649-654. 10.1097/00042737-200506000-00009, 15879727.
148. Ambrosetti P, Robert J, Witzig JA, Mirescu D, de Gautard R, Borst F, Rohner A. Incidence, outcome, and proposed management of isolated abscesses complicating acute left-sided colonic diverticulitis: a prospective study of 140 patients. Dis Colon Rectum 1992, 35:1072-1076. 10.1007/BF02252998, 1425052.
149. Siewert B, Tye G, Kruskal J, Sosna J, Opelka F, Raptopoulos V, Goldberg SN. Impact of CT-guided drainage in the treatment of diverticular abscesses: size matters. AJR Am J Roentgenol 2006, 186:680-686. [Erratum, AJR Am J Roentgenol 2007; 189:512.], 10.2214/AJR.04.1708, 16498095.
150. Kumar RR, Kim JT, Haukoos JS, Macias LH, Dixon MR, Stamos MJ, Konyalian VR. Factors affecting the successful management of intra-abdominal abscesses with antibiotics and the need for percutaneous drainage. Dis Colon Rectum 2006, 49:183-189. 10.1007/s10350-005-0274-7, 16322960.
151. McKee RF, Deignan RW, Krukowski ZH. Radiological investigation in acute diverticulitis. Br J Surg 1993, 80:560-565. 10.1002/bjs.1800800506, 8518890.
152. Padidar AM, Jeffrey RB, Mindelzun RE, Dolph JF. Differentiating sigmoid diverticulitis from carcinoma on CT scans: mesenteric inflammation suggests diverticulitis. AJR Am J Roentgenol 1994, 163:81-83.
153. Stabile BE, Puccio E, vanSonnenberg E, Neff CC. Preoperative percutaneous drainage of diverticular abscesses. Am J Surg 1990, 159:99-104. 10.1016/S0002-9610(05)80613-0, 2294804.
154. Kaiser AM, Jiang JK, Lake JP, Ault G, Artinyan A, Gonzalez-Ruiz C, Essani R, Beart RW. The management of complicated diverticulitis and the role of computed tomography. Am J Gastroenterol 2005, 100:910-917. 10.1111/j.1572-0241.2005.41154.x, 15784040.
155. Biondo S, Parés D, Martí-Ragué J, Kreisler E, Fraccalvieri D, Jaurrieta E. Acute colonic diverticulitis in patients under 50 years of age. Br J Surg 2002, 89:1137-1141. 10.1046/j.1365-2168.2002.02195.x, 12190679.
156. Schoetz DJ. Diverticular disease of the colon: a century-old problem. Dis Colon Rectum 1999, 42:703-709. 10.1007/BF02236921, 10378592.
157. Thaler K, Baig MK, Berho M, Weiss EG, Nogueras JJ, Arnaud JP, Wexner SD, Bergamaschi R. Determinants of recurrence after sigmoid resection for uncomplicated diverticulitis. Dis Colon Rectum 2003, 46:385-388. 10.1007/s10350-004-6560-y, 12626916.
158. Schwandner O, Farke S, Fischer F, Eckmann C, Schiedeck TH, Bruch HP. Laparoscopic colectomy for recurrent and complicated diverticulitis: a prospective study of 396 patients. Langenbecks Arch Surg 2004, 389:97-103. 10.1007/s00423-003-0454-7, 14985985.
159. Guller U, Jain N, Hervey S, Purves H, Pictoobon R. Laparoscopic vs. open colectomy: outcomes comparison based on large nationwide databases. Arch Surg 2003, 138:1179-1186. 10.1001/archsurg.138.11.1179, 14609864.
160. Dwivedi A, Chahin F, Agrawal S, Chau WY, Tootla A, Tootla F, Silva YJ. Laparoscopic colectomy vs. open colectomy for sigmoid diverticular disease. Dis Colon Rectum 2002, 45:1309-1314. 10.1007/s10350-004-6415-6, 12394427.
161. Tuech JJ, Pessaux P, Rouge C, Regenet N, Bergamaschi R, Arnaud JP. Laparoscopic vs. open colectomy for sigmoid diverticulitis: a prospective comparative study in the elderly. Surg Endosc 2000, 14:1031-1033. 10.1007/s004640000267, 11116412.
162. Bartus CM, Lipof T, Sarwar CM, Vignati PV, Johnson KH, Sardella WV, Cohen JL. Colovesicle fistula: not a contraindication to elective laparoscopic colectomy. Dis Colon Rectum 2005, 48:233-236. 10.1007/s10350-004-0849-8, 15616751.
163. Chapman J, Davies M, Wolff B, Dozois E, Tessier D, Harrington J, Larson D. Complicated diverticulitis: is it time to rethink the rules?. Ann Surg 2005, 242:576-581. 1402355, 16192818.
164. Ordoñez CA, Puyana JC. Management of peritonitis in the critically ill patient. Surg Clin North Am 2006, 86:1323-1349.
165. Blot S, De Waele JJ. Critical issues in the clinical management of complicated intra-abdominal infections. Drugs 2005, 65:1611-1620. 10.2165/00003495-200565120-00002, 16060697.
166. Belmonte C, Klas JV, Perez JJ, et al. The Hartmann procedure. First choice or last resort in diverticular disease?. Arch Surg 1996, 131:612-615.
167. Rothenberger DA, Wiltz O. Surgery for complicated diverticulitis. Surg Clin North Am 1993, 73:975-992.
168. Constantinides VA, Tekkis PP, Athanasiou T, Aziz O, Purkayastha S, Remzi FH, Fazio VW, Aydin N, Darzi A, Senapati A. Primary resection with anastomosis vs. Hartmann's procedure in nonelective surgery for acute colonic diverticulitis: a systematic review. Dis Colon Rectum 2006, 49:966-981. 10.1007/s10350-006-0547-9, 16752192.
169. Vermeulen J, Coene PPLO, van Hout NM, van der Harst E, Mannaerts GHH, Weidema WF, Lange JF. Restoration of bowel continuity after surgery for acute perforated diverticulitis: should Hartmann's procedure be considered a one-stage procedure?. Colorectal Dis 2009, 11:619-624. 10.1111/j.1463-1318.2008.01667.x, 18727727.
170. Nugent KP, Daniels P, Stewart B, Patankar R, Johnson CD. Quality of life in stoma patients. Dis Colon Rectum 1999, 42:1569-1574. 10.1007/BF02236209, 10613475.
171. Vermeulen J, Gosselink MP, Busschbach JJ, Lange JF. Avoiding or reversing Hartmann's procedure provides improved quality of life after perforated diverticulitis. J Gastrointest Surg 2010, 14:651-657. 10.1007/s11605-010-1155-5, 2836251, 20127201.
172. Salem L, Flum DR. Primary anastomosis or Hartmann's procedure for patients with diverticular peritonitis? A systematic review. Dis Colon Rectum 2004, 47:1953-1964. 10.1007/s10350-004-0701-1, 15622591.
173. Blair NP, Germann E. Surgical management of acute sigmoid diverticulitis. Am J Surg 2002, 183:525-528. 10.1016/S0002-9610(02)00830-9, 12034385.
174. Lee EC, Murray JJ, Coller JA, Roberts PL, Schoetz DJ. Intraoperative colonic lavage in nonelective surgery for diverticular disease. Dis Colon Rectum 1997, 40:669-674. 10.1007/BF02140895, 9194460.
175. Solomkin JS, Mazuski JE, Baron EJ, Sawyer RG, Nathens AB, DiPiro JT, Buchman T, Dellinger EP, Jernigan J, Gorbach S, Chow AW, Bartlett J, . Infectious Diseases Society of America Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections. Clin Infect Dis 2003, 15,37(8):997-1005. Infectious Diseases Society of America.
176. Weigelt JA. Empiric treatment options in the management of complicated intra-abdominal infections. Cleve Clin J Med 2007, 74(Suppl 4):S29-37. 10.3949/ccjm.74.Suppl_4.S29, 17847176.
177. Oteo J, Pérez-Vázquez M, Campos J. Extended-spectrum [beta]-lactamase producing Escherichia coli: changing epidemiology and clinical impact. Curr Opin Infect Dis 2010, 23(4):320-6. Review, 10.1097/QCO.0b013e3283398dc1, 20614578.
178. Solomkin JS, Yellin AE, Rotstein OD, Christou NV, Dellinger EP, Tellado JM, Malafaia O, Fernandez A, Choe KA, Carides A, Satishchandran V, Teppler H, . Protocol 017 Study Group Ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections: results of a double-blind,randomized comparative phase III trial. Ann Surg 2003, 237(2):235-45. 10.1097/00000658-200302000-00013, 1522141, 12560782, Protocol 017 Study Group.
179. Malangoni MA, Song J, Herrington J, Choudhri S, Pertel P. Randomized controlled trial of moxifloxacin compared with piperacillin-tazobactam and amoxicillin-clavulanate for the treatment of complicated intra-abdominal infections. Ann Surg 2006, 244(2):204-11. 10.1097/01.sla.0000230024.84190.a8, 1602153, 16858182.
180. Mazuski JE. Antimicrobial treatment for intra-abdominal infections. Expert Opin Pharmacother 2007, 8(17):2933-45. 10.1517/14656566.8.17.2933, 18001254.
181. Powell LL, Wilson SE. The role of beta-lactam antimicrobials as single agents in treatment of intra-abdominal infection. Surg Infect (Larchmt) 2000, 1(1):57-63. 10.1089/109629600321308, 12594910.
182. Lode HM. Rational antibiotic therapy and the position of ampicillin/sulbactam. Int J Antimicrob Agents 2008, 32(1):10-28. 10.1016/j.ijantimicag.2008.02.004, 18539004.
183. Gin A, Dilay L, Karlowsky JA, Walkty A, Rubinstein E, Zhanel GG. Piperacillin-tazobactam: A beta-lactam/beta-lactamase inhibitor combination. Expert Rev Anti Infect Ther 2007, 5(3):365-383. 10.1586/14787210.5.3.365, 17547502.
184. Al-Hasan MN, Lahr BD, Eckel-Passow JE, Baddour LM. Antimicrobial resistance trends of Escherichia coli bloodstream isolates: A population-based study, 1998-2007. J Antimicrob Chemother 2009, 64(1):169-174. 10.1093/jac/dkp162, 2692504, 19435736.
185. Paterson DL, Bonomo RA. Extended-Spectrum ß-Lactamases: A Clinical Update. Clin Microbiol Rev 2005, 18(4):657-686. 10.1128/CMR.18.4.657-686.2005, 1265908, 16223952.
186. Paterson DL. Resistance in gram-negative bacteria: Enterobacteriaceae. Am J Infect Control 2006, 34(5 Suppl 1):S20-8. 10.1016/j.ajic.2006.05.238, 16813978.
187. Murray BE. The life and times of the Enterococcus. Clin Microbiol Rev 1990, 3:45-65.
188. Garbino J, Villiger P, Caviezel A, Matulionyte R, Uckay I, Morel P, Lew D. A randomized prospective study of cefepime plus metronidazole with imipenem-cilastatin in the treatment of intra-abdominal infections. Infection 2007, 35(3):161-166. 10.1007/s15010-007-6237-2, 17565457.
189. Ho J, Tambyah PA, Paterson DL. Multiresistant Gram-negative infections: a global perspective. Curr Opin Infect Dis 2010, 23(6):546-53. 10.1097/QCO.0b013e32833f0d3e, 20802331.
190. Hammond ML. Ertapenem: A Group 1 carbapenem with distinct antibacterial and pharmacological properties. J Antimicrob Chemother 2004, 53(Suppl 2):ii7-9. 10.1093/jac/dkh203, 15150178.
191. Falagas ME, Peppas G, Makris GC, Karageorgopoulos DE, Matthaiou DK. Meta-analysis: Ertapenem for complicated intra-abdominal infections. Aliment Pharmacol Ther 2008, 27(10):919-931. 10.1111/j.1365-2036.2008.03642.x, 18266994.
192. Chahine EB, Ferrill MJ, Poulakos MN. Doripenem: A new carbapenem antibiotic. Am J Health Syst Pharm 2010, 67(23):2015-24. 10.2146/ajhp090672, 21098373.
193. Borcherding SM, Stevens R, Nicholas RA, Corley CR, Self T. Quinolones: A practical review of clinical uses, dosing considerations, and drug interactions. J Fam Pract 1996, 42:69-78.
194. Falagas ME, Matthaiou DK, Bliziotis IA. Systematic review: Fluoroquinolones for the treatment of intra-abdominal surgical infections. Aliment Pharmacol Ther 2007, 25(2):123-131. 10.1111/j.1365-2036.2006.03154.x, 17229237.
195. Weiss G, Reimnitz P, Hampel B, Muehlhofer E, Lippert H, . AIDA Study Group Moxifloxacin for the treatment of patients with complicated intra-abdominal infections (the AIDA Study). J Chemother 2009, 21(2):170-180. AIDA Study Group.
196. Stein GE. Pharmacokinetics and pharmacodynamics of newer fluoroquinolones. Clin Infect Dis 1996, 23(suppl 1):S19-24.
197. Edmiston CE, Krepel CJ, Seabrook GR, Somberg LR, Nakeeb A, Cambria RA, Towne JB. In vitro activities of moxifloxacin against 900 aerobic and anaerobic surgical isolates from patients with intra-abdominal and diabetic foot infections. Antimicrob Agents Chemother 2004, 48(3):1012-1016. 10.1128/AAC.48.3.1012-1016.2004, 353113, 14982797.
198. Goldstein EJ, Citron DM, Warren YA, Tyrrell KL, Merriam CV, Fernandez H. In vitro activity of moxifloxacin against 923 anaerobes isolated from human intra-abdominal infections. Antimicrob Agents Chemother 2006, 50(1):148-155. 10.1128/AAC.50.1.148-155.2006, 1346786, 16377680.
199. Solomkin J, Zhao YP, Ma EL, Chen MJ, Hampel B. DRAGON Study Team. Int J Antimicrob Agents 2009, 34(5):439-445. 10.1016/j.ijantimicag.2009.06.022, 19692210.
200. Wagner C, Sauermann R, Joukhadar C. Principles of antibiotic penetration into abscess fluid. Pharmacology 2006, 78(1):1-10. 10.1159/000094668, 16864973.
201. Bradford PA. Tigecycline: A first in class glycylcycline. Clin Microbiol Newsl 2004, 26:163-168.
202. Townsend ML, Pound MW, Drew RH. Tigecycline in the treatment of complicated intra-abdominal and complicated skin and skin structure infections. Ther Clin Risk Manag 2007, 3(6):1059-1070. 2387284, 18516315.
203. Boucher HW, Wennersten CB, Eliopoulos GM. In vitro activities of the glycylcycline GAR-936 against gram-positive bacteria. Antimicrob Agents Chemother 2000, 44:2225-2229. 10.1128/AAC.44.8.2225-2229.2000, 90048, 10898710.
204. Papaparaskevas J, Tzouvelekis LS, Tsakris A, Pittaras TE, Legakis NJ, . Hellenic Tigecycline Study Group In vitro activity of tigecycline against 2423 clinical isolates and comparison of the available interpretation breakpoints. Diagn Microbiol Infect Dis 2010, 66(2):187-194. 10.1016/j.diagmicrobio.2009.09.012, 19836184, Hellenic Tigecycline Study Group.
205. Giamarellou H, Poulakou G. Multidrug-resistant Gram-negative infections: What are the treatment options?. Drugs 2009, 69(14):1879-1901. 10.2165/11315690-000000000-00000, 19747006.
206. Hirsch EB, Tam VH. Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection. J Antimicrob Chemother 2010, 65(6):1119-25. 10.1093/jac/dkq108, 20378670.
207. Hoffmann M, DeMaio W, Jordan RA, Talaat R, Harper D, Speth J, Scatina J. Metabolism, excretion, and pharmacokinetics of [14C]tigecycline, a first-in-class glycylcycline antibiotic, after intravenous infusion to healthy male subjects. Drug Metab Dispos 2007, 35(9):1543-53. 10.1124/dmd.107.015735, 17537869.
208. Rodvold KA, Gotfried MH, Cwik M, Korth-Bradley JM, Dukart G, Ellis-Grosse EJ. Serum, tissue and body fluid concentrations of tigecycline after a single 100 mg dose. J Antimicrob Chemother 2006, 58(6):1221-9. 10.1093/jac/dkl403, 17012300.
209. Eagye KJ, Kuti JL, Dowzicky M, Nicolau DP. Empiric therapy for secondary peritonitis: a pharmacodynamic analysis of cefepime, ceftazidime, ceftriaxone, imipenem, levofloxacin, piperacillin/tazobactam, and tigecycline using Monte Carlo simulation. Clin Ther 2007, 29(5):889-99. 10.1016/j.clinthera.2007.05.018, 17697907.
210. Babinchak T, Ellis-Grosse E, Dartois N, Rose GM, Loh E, . Tigecycline 301 Study Group The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data. Clin Infect Dis 2005, 41(Suppl 5):S354-67. 10.1086/431676, 16080073, Tigecycline 301 Study Group.
211. Towfigh S, Pasternak J, Poirier A, Leister H, Babinchak T. A multicentre, open-label, randomized comparative study of tigecycline versus ceftriaxone sodium plus metronidazole for the treatment of hospitalized subjects with complicated intra-abdominal infections. Clin Microbiol Infect 2010, 16(8):1274-81. 10.1111/j.1469-0691.2010.03122.x, 20670293.
212. Yoshida M, Takada T, Kawarada Y, et al. Antimicrobial therapy for acute cholecystitis: Tokyo Guidelines. J Hepatobiliary Pancreat Surg 2007, 14:83-90. 10.1007/s00534-006-1160-y, 2784497, 17252301.
213. Takada T, Kawarada Y, Nimura Y, et al. Background: Tokyo Guidelines for the management of acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Surg 2007, 14:1-10. 10.1007/s00534-006-1150-0, 2784507, 17252291.
214. Mayumi T, Takada T, Kawarada Y, et al. Results of the Tokyo Consensus Meeting Tokyo Guidelines. J Hepatobiliary Pancreat Surg 2007, 14:114-21. 10.1007/s00534-006-1163-8, 2784505, 17252304.
215. Kiviluoto T, Sirén J, Luukkonen P, Kivilaakso E. Randomised trial of laparoscopic versus open cholecystectomy for acute and gangrenous cholecystitis. Lancet 1998, 351(9099):321-5. 10.1016/S0140-6736(97)08447-X, 9652612.
216. Johansson M, Thune A, Nelvin L, Stiernstam M, Westman B, Lundell L. Randomized clinical trial of open versus laparoscopic cholecystectomy in the treatment of acute cholecystitis. Br J Surg 2005, 92(1):44-9. 10.1002/bjs.4836, 15584058.
217. Kum CK, Goh PMY, Isaac JR, Tekant Y, Ngoi SS. Laparoscopic cholecystectomy for acute cholecystitis. Br J Surg 1994, 81:1651-1654. 10.1002/bjs.1800811130, 7827896.
218. Chau CH, Tang CN, Siu WT, Ha JP, Li MK. Laparoscopic cholecystectomy versus open cholecystectomy in elderly patients with acute cholecystitis: retrospective study. Hong Kong Med 2002, J8:394-399.
219. Pessaux P, Regenet N, Tuech JJ, Rouge C, Bergamaschi R, Arnaud JP. Laparoscopic versus open cholecystectomy: a prospective comparative study in the elderly with acute cholecystitis. Surg Laparosc Endosc Percutan Tech 2001, 11:252-255. 10.1097/00129689-200108000-00005, 11525370.
220. Lujan JA, Parrilla P, Robles R, Marin P, Torralba JA, Garcia-Ayllon J. Laparoscopic chole cystectomy vs open cholecystectomy in the treatment of acute cholecystitis: a prospective study. Arch Surg 1998, 133:173-175. 10.1001/archsurg.133.2.173, 9484730.
221. Gurusamy K, Samraj K, Gluud C, Wilson E, Davidson BR. Meta-analysis of randomized controlled trials on the safety and effectiveness of early versus delayed laparoscopic cholecystectomy for acute cholecystitis. Br J Surg 2010, 97(2):141-50. 10.1002/bjs.6870, 20035546.
222. Siddiqui T, MacDonald A, Chong PS, Jenkins JT. Early versus delayed laparoscopic cholecystectomy for acute cholecystitis: a meta-analysis of randomized clinical trials. Am J Surg 2008, 195(1):40-7. 10.1016/j.amjsurg.2007.03.004, 18070735.
223. Lau H, Lo CY, Patil NG, Yuen WK. Early versus delayed-interval laparoscopic cholecystectomy for acute cholecystitis: a meta-analysis. Surg Endosc 2006, 20(1):82-7. 10.1007/s00464-005-0100-2, 16247580.
224. Papi C, Catarci M, D'Ambrosio L, Gili L, Koch M, Grassi GB, Capurso L. Timing of cholecystectomy for acute calculous cholecystitis: a meta-analysis. Am J Gastroenterol 2004, 99(1):147-55. 10.1046/j.1572-0241.2003.04002.x, 14687156.
225. Hadad SM, Vaidya JS, Baker L, Koh HC, Heron TP, Hussain K, Thompson AM. Delay from symptom onset increases the conversion rate in laparoscopic cholecystectomy for acute cholecystitis. World J Surg 2007, 31(6):1298-01. discussion 1302-3., 10.1007/s00268-007-9050-2, 17483986.
226. Winbladh A, Gullstrand P, Svanvik J, Sandström P. Systematic review of cholecystostomy as a treatment option in acute cholecystitis. HPB (Oxford) 2009, 11(3):183-93. 2697889, 19590646.
227. Menakuru SR, Kaman L, Behera A, Singh R, Katariya RN. Current management of gall bladder perforations. ANZ J Surg 2004, 74:843-846. 10.1111/j.1445-1433.2004.03186.x, 15456428.
228. Roslyn JJ, Thompson JE, Darvin H, DenBesten L. Risk factors for gallbladder perforation. Am J Gastroenterol 1987, 82:636-640.
229. Ong CL, Wong TH, Rauff A. Acute gall bladder perforation-a dilemma in early diagnosis. Gut 1991, 32:956-958. 10.1136/gut.32.8.956, 1378971, 1885081.
230. Stefanidis D, Sirinek KR, Bingener J. Gallbladder perforation: risk factors and outcome. J Surg Res 2006, 131(2):204-8. Epub 2006 Jan 18, 10.1016/j.jss.2005.11.580, 16412466.
231. O'Connor MJ, Schwartz ML, McQuarrie DG, Sumer HW. Acute bacterial cholangitis: an analysis of clinical manifestation. Arch Surg 1982, 117:437-41. 2.
232. Welch JP, Donaldson GA. The urgency of diagnosis and surgical treatment of acute suppurative cholangitis. Am J Surg 1976, 131:527-32. 10.1016/0002-9610(76)90003-9, 1275137.
233. Lai EC, Mok FP, Tan ES, Lo CM, Fan ST, You KT, Wong J. Endoscopic biliary drainage for severe acute cholangitis. N Engl J Med 1992, 24:1582-6.
234. Lee DWH, Chung SCS. Biliary infection. Baillieres Clin Gastroenterol 1997, 11:707-24. 10.1016/S0950-3528(97)90017-8, 9512806.
235. Lipsett PA, Pitt HA. Acute cholangitis. Surg Clin North Am 1990, 70:1297-312.
236. Hanau LH, Steigbigel NH. Acute cholangitis. Infect Dis Clin North Am 2000, 14:521-46. 10.1016/S0891-5520(05)70119-7, 10987108.
237. Lee JG. Diagnosis and management of acute cholangitis. Nat Rev Gastroenterol Hepatol 2009, 6(9):533-41. 10.1038/nrgastro.2009.126, 19652653.
238. Saltzstein EC, Peacock JB, Mercer LC. Early operation for acute biliary tract stone disease. Surgery 1983, 94:704-8.
239. Westphal JF, Brogard JM. Biliary tract infections: a guide to drug treatment. Drugs 1999, 57(1):81-91. 10.2165/00003495-199957010-00007, 9951953.
240. Jarvinen H. Biliary bacteremia at various stages of acute cholecystitis. Acta Chir Scand 1980, 146:427-30.
241. Westphal J, Brogard J. Biliary tract infections: a guide to drug treatment. Drugs 1999, 57:81-91. 10.2165/00003495-199957010-00007, 9951953.
242. Sinanan M. Acute cholangitis. Infect Dis Clin North Am 1992, 6:571-99.
243. Blenkharn J, Habib N, Mok D, John L, McPherson G, Gibson R, et al. Decreased biliary excretion of piperacillin after percutaneous relief of extrahepatic obstructive jaundice. Antimicrob Agents Chemother 1985, 28:778-80. 180327, 4083861.
244. van den Hazel S, De Vries X, Speelman P, Dankert J, Tytgat G, Huibregtse K, et al. Biliary excretion of ciprofloxacin and piperacillin in the obstructed biliary tract. Antimicrob Agents Chemother 1996, 40:2658-60. 163596, 8913485.
245. Levi J, Martinez O, Malinin T, Zeppa R, Livingstone A, Hutson D, et al. Decreased biliary excretion of cefamandole after percutaneous biliary decompression in patients with total common bile duct obstruction. Antimicrob Agents Chemother 1984, 26:944-6. 180059, 6524908.
246. Tanaka A, Takada T, Kawarada Y, Nimura Y, Yoshida M, Miura F, Hirota M, Wada K, Mayumi T, Gomi H, Solomkin JS, Strasberg SM, Pitt HA, Belghiti J, de Santibanes E, Padbury R, Chen MF, Belli G, Ker CG, Hilvano SC, Fan ST, Liau KH. Antimicrobial therapy for acute cholangitis: Tokyo Guidelines. J Hepatobiliary Pancreat Surg 2007, 14(1):59-67. Epub 2007 Jan 30, 10.1007/s00534-006-1157-6, 2784514, 17252298.
247. Pacelli F, Doglietto GB, Alfieri S, et al. Prognosis in intraabdominal infection. Multivariate analysis in 604 patients. Arch Surg 1996, 131:641-645.
248. Roehrborn A, Thomas L, Potreck O, Ebener C, Ohmann C, Goretzki P, Röher H. The microbiology of postoperative peritonitis. Clin Infect Dis 2001, 33:1513-1519. 10.1086/323333, 11568851.
249. Torer N, Yorganci K, Elker D, Sayek I. Prognostic factors of the mortality of postoperative intraabdominal infections. Infection 2010,
250. Mulier S, Penninckx F, Verwaest C, Filez L, Aerts R, Fieuws S, Lauwers P. Factors affecting ortality in generalized postoperative peritonitis: multivariate analysis in 96 patients. World J Surg 2003, 27(4):379-84. 10.1007/s00268-002-6705-x, 12658477.
251. Khamphommala L, Parc Y, Bennis M, Ollivier JM, Dehni N, Tiret E, Parc R. Results of an aggressive surgical approach in the management of postoperative peritonitis. ANZ J Surg 2008, 78(10):881-8. 10.1111/j.1445-2197.2008.04685.x, 18959642.
252. Parc Y, Frileux P, Schmitt G, Dehni N, Ollivier JM, Parc R. Management of postoperative peritonitis after anterior resection: experience from a referral intensive care unit. Dis Colon Rectum 2000, 43(5):579-587. 10.1007/BF02235565, 10826415.
253. Bohnen J, Boulanger M, Meakins JL, McLean AP. Prognosis in generalized peritonitis. Relation to cause and risk factors. Arch Surg 1983, 118(3):285-90.
254. Montravers P, Chalfine A, Gauzit R, Lepape A, Pierre Marmuse J, Vouillot C, Martin C. Clinical and therapeutic features of nonpostoperative nosocomial intra-abdominal infections. Ann Surg 2004, 239(3):409-16. 10.1097/01.sla.0000114214.68169.e9, 1356241, 15075660.
255. Ordoñez CA, Puyana JC. Management of peritonitis in the critically ill patient. Surg Clin North Am 2006, 86(6):1323-49.
256. Inui T, Haridas M, Claridge JA, Malangoni MA. Mortality for intra-abdominal infection is associated with intrinsic risk factors rather than the source of infection. Surgery 2009, 146(4):654-61. discussion 661-2.ct;146(4):654-61; discussion 661-2., 10.1016/j.surg.2009.06.051, 19789024.
257. Theisen J, Bartels H, Weiss W, Berger H, Stein HJ, Siewert JR. Current concepts of percutaneous abscess drainage in postoperative retention. J Gastrointest Surg 2005, 9(2):280-3. 10.1016/j.gassur.2004.04.008, 15694825.
258. Khurrum Baig M, Hua Zhao R, Batista O, Uriburu JP, Singh JJ, Weiss EG, Nogueras JJ, Wexner SD. Percutaneous postoperative intra-abdominal abscess drainage after elective colorectal surgery. Tech Coloproctol 2002, 6(3):159-64. 10.1007/s101510200036, 12525909.
259. Benoist S, Panis Y, Pannegeon V, Soyer P, Watrin T, Boudiaf M, Valleur P. Can failure of percutaneous drainage of postoperative abdominal abscesses be predicted?. Am J Surg 2002, 184(2):148-53. 10.1016/S0002-9610(02)00912-1, 12169359.
260. Koperna T, Schulz F. Prognosis and treatment of peritonitis. Do we need new scoring systems?. Arch Surg 1996, 131(2):180-6.
261. Koperna T, Schulz F. Relaparotomy in peritonitis: prognosis and treatment of patients with persisting intraabdominal infection. World J Surg 2000, 24(1):32-7. 10.1007/s002689910007, 10594200.
262. Farthmann EH, Schoffel U. Principles and limitations of operative management of intraabdominal infections. World J Surg 1990, 14(2):210-217. 10.1007/BF01664875, 2183484.
263. Hutchins RR, Gunning MP, Lucas DN, Allen-Mersh TG, Soni NC. Relaparotomy for suspected intraperitoneal sepsis after abdominal surgery. World J Surg 2004, 28(2):137-41. 10.1007/s00268-003-7067-8, 14708056.
264. van Ruler O, Lamme B, Gouma DJ, Reitsma JB, Boermeester MA. Variables associated with positive findings at relaparotomy in patients with secondary peritonitis. Crit Care Med 2007, 35(2):468-76. 10.1097/01.CCM.0000253399.03545.2D, 17205025.
265. Hutchins RR, Gunning MP, Lucas DN, Allen-Mersh TG, Soni NC. Relaparotomy for suspected intraperitoneal sepsis after abdominal surgery. World J Surg 2004, 28(2):137-41. 10.1007/s00268-003-7067-8, 14708056.
266. Lamme B, Mahler CW, van Ruler O, Gouma DJ, Reitsma JB, Boermeester MA. Clinical predictors of ongoing infection in secondary peritonitis: systematic review. World J Surg 2006, 30(12):2170-81. 10.1007/s00268-005-0333-1, 17102920.
267. van Ruler O, Mahler CW, Boer KR, Reuland EA, Gooszen HG, Opmeer BC, de Graaf PW, Lamme B, Gerhards MF, Steller EP, van Till JW, de Borgie CJ, Gouma DJ, Reitsma JB, Boermeester MA, . Dutch Peritonitis Study Group Comparison of on-demand vs planned relaparotomy strategy in patients with severe peritonitis: a randomized trial. JAMA 2007, 298(8):865-72. 10.1001/jama.298.8.865, 17712070, Dutch Peritonitis Study Group.
268. Amin AI, Shaikh IA. Topical negative pressure in managing severe peritonitis: a positive contribution?. World J Gastroenterol 2009, 15(27):3394-7. 10.3748/wjg.15.3394, 2712900, 19610140.
269. Adkins AL, Robbins J, Villalba M, Bendick P, Shanley CJ. Open abdomen management of intra-abdominal sepsis. Am Surg 2004, 70:137-140.
270. Schein M. Planned reoperations and open management in critical intra-abdominal infections: prospective experience in 52 cases. World J Surg 1991, 15:537-545. 10.1007/BF01675658, 1832509.
271. Robledo FA, Luque-de-León E, Suárez R, Sánchez P, de-la-Fuente M, Vargas A, Mier J. Open versus closed management of the abdomen in the surgical treatment of severe secondary peritonitis: a randomized clinical trial. Surg Infect Larchmt 2007, 8(1):63-72. 10.1089/sur.2006.8.016, 17381398.
272. Linden PK. Optimizing therapy for vancomycin-resistant Enterococci (VRE). Semin Respir Crit Care Med 2007, 28:632-645. 10.1055/s-2007-996410, 18095227.
273. Chou YY, Lin TY, Lin JC, Wang NC, Peng MY, Chang FY. Vancomycin-resistant enterococcal bacteremia: Comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis. J Microbiol Immunol Infect 2008, 41(2):124-129.
274. Jean SS, Fang CT, Wang HK, Hsueh PR, Chang SC, Luh KT. Invasive infections due to vancomycin-resistant Enterococci in adult patients. J Microbiol Immunol Infect 2001, 34:281-286.
275. Noskin GA. Vancomycin-resistant Enterococci: Clinical, microbiologic, and epidemiologic features. J Lab Clin Med 1997, 130:14-20. 10.1016/S0022-2143(97)90054-8, 9242362.
276. Blot SI, Vandewoude KH, De Waele JJ. Candida peritonitis. Curr Opin Crit Care 2007, 13(2):195-199. 10.1097/MCC.0b013e328028fd92, 17327742.
277. Senn L, Eggimann P, Ksontini R, Pascual A, Demartines N, Bille J, Calandra T, Marchetti O. Caspofungin for prevention of intra-abdominal candidiasis in high-risk surgical patients. Intensive Care Med 2009, 35(5):903-908. 10.1007/s00134-009-1405-8, 19172247.
278. Pappas PG, Kauffman CA, Andes D, Benjamin DK, Calandra TF, Edwards JE, Filler SG, Fisher JF, Kullberg BJ, Ostrosky-Zeichner L, Reboli AC, Rex JH, Walsh TJ, Sobel JD, . Infectious Diseases Society of America Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009, 1;48(5):503-35. Infectious Diseases Society of America.